Evaluation of the use of midline peripheral catheters for the purpose of blood collection
Little is known or reported about the procedures used to sample blood from midline catheters or outcomes from using the MC for this purpose.
Tangent Medical secures $5M from GE Capital to take IV tech abroad
University of Michigan spinout Tangent Medical has raised a $5 million senior secured term loan credit facility from GE Capital, Healthcare Financial Services to commercialize its IV stabilization tech abroad. While company Vice President of Sales and Marketing Curtis Bloch said the funding will be used for a variety of commercialization efforts, a significant portion would be used […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
3-D St. Jude Medical launches technology that gives docs real-time, 360-degree view of arteries
St. Jude Medical (STJ) announced FDA approval of its ILUMIEN OPTIS PCI Optimization System, and the product’s U.S. launch. The device gives physicians a real-time, 360-degree panoramic view of the arteries, to help with stent placement and to guide treatment for patients with coronary artery disease. But what’s the true value proposition between this new […]
Tennessee medical device company gets FDA nod for Occlusion Perfusion Catheter
Chattanooga, Tenn.-based Advanced Catheter Therapies received FDA 510(k) clearance for its Occlusion Perfusion Catheter, a multi-lumen balloon catheter on Tuesday. The medical device technology can measure pressure inside the treatment chamber, as well as “its inflow and outflow ports for chamber evacuation, filling and flushing,” according to a press release. The catheter is designed to […]
Volcano Corp. to acquire Medtronic’s Pioneer Plus technology, move into therapeutics
Medtronic (MDT) is selling off endovascular technology. Volcano Corporation (VOLC) will acquire Medtronic’s Pioneer Plus diagnostic ultrasound transducer and percutaneous catheter in a deal that should close by the end of the week. Volcano will use Pioneer Plus to increase its presence in the diagnosis and treatment of peripheral arterial disease. The acquisition moves the […]
BSX gets FDA approval for ablation catheter, becomes third major player this week with ablation milestone
Boston Scientific (BSX) announced it has received U.S. Food and Drug Administration approval for its IntellaTip MiFi XP catheter and 501(k) clearance for its Zurpaz 8.5F steerable sheath, growing its EP mapping/ablation technology portfolio. This makes it the third major player–following both St. Jude Medical, which acquired Endosense, and GE, which invested in Acutus Medical–to […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
St. Jude Medical banks $170M on contact force ablation tech in growing A-fib market
As predicted, the next incremental advances in the growing A-fib heart space may very well be in contact force catheter technology. St. Jude’s Medical is banking on it. The company just acquired Endosense, a Switzerland company that creates contact force ablation catheter technology, for $170 million. If Endosense meets an undisclosed regulatory milestone, it could […]
FDA approves St. Jude’s ablation catheter for MediGuide platform
EP mapping (and the catheters that go with them) continues to be a hot topic in cardiac. St. Jude Medical adds an approved ablation catheter enabled to work with its prize hen, MediGuide Technology, the EP 3-D navigation platform that “allows physician to see the exact location and orientation of devices” inside a patient’s heart […]
If you have a horse in the $2.4B A-fib race, hedge your bets with these 3 strategies
It’s a good time to enter the EP-mapping and ablation device market, as Millennium Research Group reports, the more and more popular A-fib ablation procedure will drive those areas toward a value of more than $2.4 billion by 2021. The increase in atrial fibrillation ablations will drive strong growth in the electrophysiology (EP)-mapping and the […]